Literature DB >> 34919689

A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease.

Ramesh Kandimalla1,2, Maria Manczak1, Jangampalli Adi Pradeepkiran3, Hallie Morton3, P Hemachandra Reddy1,3,4,5,6,7.   

Abstract

The purpose of our study is to understand the impact of a partial dynamin-related protein 1 (Drp1) on cognitive behavior, mitophagy, autophagy and mitochondrial and synaptic activities in transgenic Tau mice in Alzheimer's disease (AD). Our laboratory reported increased levels of amyloid-beta (Aβ) and phosphorylated Tau (P-Tau) and reported that abnormal interactions between Aβ and Drp1, P-Tau and Drp1 induced increased mitochondrial fragmentation and reduced fusion and synaptic activities in AD. These abnormal interactions result in the proliferation of dysfunctional mitochondria in AD neurons. Recent research on mitochondria revealed that fission protein Drp1 is largely implicated in mitochondrial dynamics in AD. To determine the impact of reduced Drp1 in AD, we recently crossed transgenic Tau mice with Drp1 heterozygote knockout (Drp1+/-) mice and generated double mutant (P301LDrp1+/-) mice. In the current study, we assessed the cognitive behavior, mRNA and protein levels of mitophagy, autophagy, mitochondrial biogenesis, dynamics and synaptic genes, mitochondrial morphology and mitochondrial function and dendritic spines in Tau mice relative to double mutant mice. When compared with Tau mice, double mutant mice did better on the Morris Maze (reduced latency to find hidden platform, increased swimming speed and time spent on quadrant) and rotarod (stayed a longer period of time) tests. Both mRNA- and protein-level autophagy, mitophagy, mitochondrial biogenesis and synaptic proteins were increased in double mutant mice compared with Tau (P301L) mice. Dendritic spines were significantly increased; mitochondrial number was reduced and length was increased in double mutant mice. Based on these observations, we conclude that reduced Drp1 is beneficial in a symptomatic-transgenic Tau (P301L) mice.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34919689      PMCID: PMC9169458          DOI: 10.1093/hmg/ddab360

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  43 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

2.  Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.

Authors:  Maria Manczak; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2012-02-24       Impact factor: 6.150

3.  Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons.

Authors:  Qian Cai; Hesham Mostafa Zakaria; Anthony Simone; Zu-Hang Sheng
Journal:  Curr Biol       Date:  2012-02-16       Impact factor: 10.834

4.  Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Authors:  Ramesh Kandimalla; Maria Manczak; David Fry; Yeguvapalli Suneetha; Hiromi Sesaki; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

5.  Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; David Fry; Hiromi Sesaki; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

Review 6.  Intracellular amyloid-beta in Alzheimer's disease.

Authors:  Frank M LaFerla; Kim N Green; Salvatore Oddo
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

Review 7.  Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.

Authors:  Hallie Morton; Sudhir Kshirsagar; Erika Orlov; Lloyd E Bunquin; Neha Sawant; Lauren Boleng; Mathew George; Tanisha Basu; Bhagavathi Ramasubramanian; Jangampalli Adi Pradeepkiran; Subodh Kumar; Murali Vijayan; Arubala P Reddy; P Hemachandra Reddy
Journal:  Free Radic Biol Med       Date:  2021-07-08       Impact factor: 7.376

8.  The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice.

Authors:  Junko Wakabayashi; Zhongyan Zhang; Nobunao Wakabayashi; Yasushi Tamura; Masahiro Fukaya; Thomas W Kensler; Miho Iijima; Hiromi Sesaki
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

Review 9.  Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Darryll Ma Oliver
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

Review 10.  Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria.

Authors:  Albin John; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2020-11-04       Impact factor: 10.895

View more
  6 in total

1.  Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.

Authors:  Sanjib Guha; Anson Cheng; Trae Carroll; Dennisha King; Shon A Koren; Sierra Swords; Keith Nehrke; Gail V W Johnson
Journal:  Genetics       Date:  2022-08-30       Impact factor: 4.402

Review 2.  Mitophagy: An Emergence of New Player in Alzheimer's Disease.

Authors:  Bunty Sharma; Deeksha Pal; Ujjawal Sharma; Aman Kumar
Journal:  Front Mol Neurosci       Date:  2022-07-06       Impact factor: 6.261

Review 3.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

Review 4.  Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Authors:  Jangampalli Adi Pradeepkiran; Ashly Hindle; Sudhir Kshirsagar; P Hemachandra Reddy
Journal:  Biomed Pharmacother       Date:  2022-04-04       Impact factor: 7.419

5.  Aerobic Exercise Alleviates Abnormal Autophagy in Brain Cells of APP/PS1 Mice by Upregulating AdipoR1 Levels.

Authors:  Ye Jian; Shunling Yuan; Jialun Yang; Yong Lei; Xuan Li; Wenfeng Liu
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

6.  A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease.

Authors:  Sudhir Kshirsagar; Rainier Vladlen Alvir; Jangampalli Adi Pradeepkiran; Ashly Hindle; Murali Vijayan; Bhagavathi Ramasubramaniam; Subodh Kumar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.